Lysosomal and Rare Disorders Research and Treatment Center Inc

Analysis

Lysosomal and Rare Disorders Research and Treatment Center Inc is a registered charity in United States, based in Fairfax, VA. It received its IRS tax-exemption ruling in July 2021, 5 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Lysosomal and Rare Disorders Research and Treatment Center Inc reported income of $3.4m and spending of $3.7m, spending 110% of what it took in. Across the 6 years on record, from December 2016 to December 2023, income grew from $375k to $3.4m (+793%), an average of +55% a year. The sharpest change came in the year to December 2019, when income rose by 421%. Over the whole period it spent 96% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Lysosomal and Rare Disorders Research and Treatment Center Inc sits at the 76th percentile: it is larger than about 76% of them. Against every charity in United States with reported income it ranks in the 90th percentile, and in the 90th percentile within VA. Charities of a similar size with the same main cause include Eastport Memorial Hospital ($3.4m), Wilton Emergency Squad Inc ($3.4m) and The Brett Boyer Foundation Inc ($3.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 15% and program service revenue 85% of the total. Compensation of current officers, directors and key employees was $552k (15% of expenses). Other salaries and wages came to $611k. At year end it held assets of $1.9m against liabilities of $961k, net assets of $891k. It reported 26 employees.